Alcobra Announces Leadership Update

Dr. Yaron Daniely to Step Down as Chief Executive Officer, Effective May 31, 2017 David Baker Named Interim Chief Executive Officer Dr. Daniely to Remain on Board of Directors and be Appointed Chairman TEL AVIV, Israel, May 15, 2017 -- (Healthcare... Biopharmaceuticals, Personnel Alcobra, MDX, ADAIR
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news